Gene: KDELR2
Official Full Name: KDEL endoplasmic reticulum protein retention receptor 2provided by HGNC
Gene Summary: Retention of resident soluble proteins in the lumen of the endoplasmic reticulum (ER) is achieved in both yeast and animal cells by their continual retrieval from the cis-Golgi, or a pre-Golgi compartment. Sorting of these proteins is dependent on a C-terminal tetrapeptide signal, usually lys-asp-glu-leu (KDEL) in animal cells, and his-asp-glu-leu (HDEL) in S. cerevisiae. This process is mediated by a receptor that recognizes, and binds the tetrapeptide-containing protein, and returns it to the ER. In yeast, the sorting receptor encoded by a single gene, ERD2, is a seven-transmembrane protein. Unlike yeast, several human homologs of the ERD2 gene, constituting the KDEL receptor gene family, have been described. KDELR2 was the second member of the family to be identified, and it encodes a protein which is 83% identical to the KDELR1 gene product. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31327 | KDELR2 Knockout cell line (HeLa) | Human | KDELR2 | 1:3~1:6 | Negative | Online Inquiry |
KO31328 | KDELR2 Knockout cell line (HCT 116) | Human | KDELR2 | 1:2~1:4 | Negative | Online Inquiry |
KO31329 | KDELR2 Knockout cell line (HEK293) | Human | KDELR2 | 1:3~1:6 | Negative | Online Inquiry |
KO31330 | KDELR2 Knockout cell line (A549) | Human | KDELR2 | 1:3~1:4 | Negative | Online Inquiry |
KDELR2 Gene Knockout Cell Lines are a sophisticated biological tool designed for researchers investigating the role of the KDELR2 gene in cellular functions and disease mechanisms. These cell lines have been genetically engineered to lack the KDELR2 gene, enabling detailed studies of its physiological and pathological implications. By systematically disrupting this gene, researchers can observe the resultant phenotypic changes, thus gaining insights into KDELR2's involvement in processes such as protein trafficking and cellular stress responses.
The primary function of KDELR2 is to act as a receptor for escaped endoplasmic reticulum (ER) proteins, signaling their retrieval back to the ER. In the context of KDELR2 knockout, researchers can elucidate alternative pathways that might compensate for its absence or reveal new biomarkers associated with cellular stress and survival mechanisms. This functional complementation is especially pertinent in cancer research, where altered protein processing features prominently.
The scientific importance of KDELR2 Gene Knockout Cell Lines is underscored by their applications in both fundamental research and clinical settings. These cell lines serve as invaluable assets for drug discovery, allowing for high-throughput screening assays to identify compounds that may modulate the activities of related pathways. Additionally, they can provide insights into the molecular basis of diseases linked to dysfunctional protein trafficking, such as neurodegenerative disorders.
Compared to alternatives, such as transient gene silencing approaches or overexpression systems, KDELR2 knockout cell lines present distinct advantages. They offer stable, long-term genetic alterations that facilitate reproducibility and consistency across experiments. Moreover, the specificity of knockout lines minimizes off-target effects often observed with RNA interference techniques, enhancing the validity of experimental results.
For researchers and clinicians focused on cellular stress responses, protein misfolding diseases, or cancer biology, KDELR2 Gene Knockout Cell Lines represent a transformative resource, paving the way toward novel therapeutic strategies. Our company prides itself on its commitment to providing high-quality, rigorously validated biological products, coupled with extensive technical support to enhance your research capabilities. We continue to advance the frontiers of biological sciences through innovative solutions tailored to meet your research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.